Corcept Therapeutics | CORT - Текущие активы





Текущие активы Изменить Дата
Acadia Pharmaceuticals USD 1.22B 128.53M 2026-06
Alaunos Therapeutics USD 970K 1.02M 2026-03
ANI Pharmaceuticals USD 825.43M 78.35M 2026-06
Ardelyx USD 381.87M 447K 2026-03
Aurora Cannabis CAD 397.45M 48.38M 2026-03
BioMarin Pharmaceutical USD 3.97B 633.45M 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Canopy Growth CAD 529.47M 4.8M 2026-03
Corcept Therapeutics USD 439.68M 13.64M 2026-06
Eli Lilly USD 64.67B 9.84B 2026-06
J&J USD 59.77B 601M 2026-06
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Lexicon Pharmaceuticals USD 186.03M 84.14M 2026-03
Merck USD 36.68B 1.66B 2026-06
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Novartis USD 27.35B 744M 2026-06
Novartis USD 26.61B 3.85B 2026-03
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 615.21M 100.25M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Supernus Pharmaceuticals USD 723.5M 8.08M 2026-06
TG Therapeutics USD 1.15B 58.72M 2026-06